# Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

> **NCT00003943** · PHASE2 · COMPLETED · sponsor: **Fox Chase Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Carcinoma of Unknown Primary
- Lung Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** paclitaxel
- **DRUG:** topotecan hydrochloride
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00003943
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 2000-11
- **Final completion:** 2003-02
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2013-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003943, "Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00003943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*